Cargando…

Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins

BACKGROUND: Ever since their discovery, induced pluripotent stem cells (iPSCs) have been extensively differentiated into a large variety of cell types. However, a limited amount of work has been dedicated to differentiating iPSCs into osteoclasts. While several differentiation protocols have been pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Blümke, Alexander, Ijeoma, Erica, Simon, Jessica, Wellington, Rachel, Purwaningrum, Medania, Doulatov, Sergei, Leber, Elizabeth, Scatena, Marta, Giachelli, Cecilia M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350192/
https://www.ncbi.nlm.nih.gov/pubmed/37461708
http://dx.doi.org/10.21203/rs.3.rs-3089289/v1
_version_ 1785074083350708224
author Blümke, Alexander
Ijeoma, Erica
Simon, Jessica
Wellington, Rachel
Purwaningrum, Medania
Doulatov, Sergei
Leber, Elizabeth
Scatena, Marta
Giachelli, Cecilia M
author_facet Blümke, Alexander
Ijeoma, Erica
Simon, Jessica
Wellington, Rachel
Purwaningrum, Medania
Doulatov, Sergei
Leber, Elizabeth
Scatena, Marta
Giachelli, Cecilia M
author_sort Blümke, Alexander
collection PubMed
description BACKGROUND: Ever since their discovery, induced pluripotent stem cells (iPSCs) have been extensively differentiated into a large variety of cell types. However, a limited amount of work has been dedicated to differentiating iPSCs into osteoclasts. While several differentiation protocols have been published, it remains unclear which protocols or differentiation methods are preferrable regarding the differentiation of osteoclasts. METHODS: In this study we compare the osteoclastogenesis capacity of a peripheral blood mononuclear cell (PBMC)-derived iPSC line to a fibroblast-derived iPSC line in conjunction with either embryoid body-based or monolayer-based differentiation strategies. Both cell lines and differentiation protocols were investigated regarding their ability to generate osteoclasts and their inherent robustness and ease of use. The ability of both cell lines to remain undifferentiated while propagating using a feeder-free system was assessed using alkaline phosphatase staining. This was followed by evaluating mesodermal differentiation and the characterization of hematopoietic progenitor cells using flow cytometry. Finally, osteoclast yield and functionality based on resorptive activity, Cathepsin K and tartrate-resistant acid phosphatase (TRAP) expression were assessed. Results were validated using qRT-PCR throughout the differentiation stages. RESULTS: Embryoid-body based differentiation yielded CD45(+), CD14(+), CD11b(+) subpopulations which in turn differentiated into osteoclasts which demonstrated TRAP positivity, Cathepsin K expression and mineral resorptive capabilities. This was regardless of which iPSC line was used. Monolayer-based differentiation yielded lower quantities of hematopoietic cells that were mostly CD34(+) and did not subsequently differentiate into osteoclasts. CONCLUSIONS: The outcome of this study demonstrates the successful differentiation of osteoclasts from iPSCs in conjunction with the embryoid-based differentiation method, while the monolayer-based method did not yield osteoclasts. No differences were observed regarding osteoclast differentiation between the PBMC and fibroblast-derived iPSC lines.
format Online
Article
Text
id pubmed-10350192
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-103501922023-07-17 Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins Blümke, Alexander Ijeoma, Erica Simon, Jessica Wellington, Rachel Purwaningrum, Medania Doulatov, Sergei Leber, Elizabeth Scatena, Marta Giachelli, Cecilia M Res Sq Article BACKGROUND: Ever since their discovery, induced pluripotent stem cells (iPSCs) have been extensively differentiated into a large variety of cell types. However, a limited amount of work has been dedicated to differentiating iPSCs into osteoclasts. While several differentiation protocols have been published, it remains unclear which protocols or differentiation methods are preferrable regarding the differentiation of osteoclasts. METHODS: In this study we compare the osteoclastogenesis capacity of a peripheral blood mononuclear cell (PBMC)-derived iPSC line to a fibroblast-derived iPSC line in conjunction with either embryoid body-based or monolayer-based differentiation strategies. Both cell lines and differentiation protocols were investigated regarding their ability to generate osteoclasts and their inherent robustness and ease of use. The ability of both cell lines to remain undifferentiated while propagating using a feeder-free system was assessed using alkaline phosphatase staining. This was followed by evaluating mesodermal differentiation and the characterization of hematopoietic progenitor cells using flow cytometry. Finally, osteoclast yield and functionality based on resorptive activity, Cathepsin K and tartrate-resistant acid phosphatase (TRAP) expression were assessed. Results were validated using qRT-PCR throughout the differentiation stages. RESULTS: Embryoid-body based differentiation yielded CD45(+), CD14(+), CD11b(+) subpopulations which in turn differentiated into osteoclasts which demonstrated TRAP positivity, Cathepsin K expression and mineral resorptive capabilities. This was regardless of which iPSC line was used. Monolayer-based differentiation yielded lower quantities of hematopoietic cells that were mostly CD34(+) and did not subsequently differentiate into osteoclasts. CONCLUSIONS: The outcome of this study demonstrates the successful differentiation of osteoclasts from iPSCs in conjunction with the embryoid-based differentiation method, while the monolayer-based method did not yield osteoclasts. No differences were observed regarding osteoclast differentiation between the PBMC and fibroblast-derived iPSC lines. American Journal Experts 2023-07-07 /pmc/articles/PMC10350192/ /pubmed/37461708 http://dx.doi.org/10.21203/rs.3.rs-3089289/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Blümke, Alexander
Ijeoma, Erica
Simon, Jessica
Wellington, Rachel
Purwaningrum, Medania
Doulatov, Sergei
Leber, Elizabeth
Scatena, Marta
Giachelli, Cecilia M
Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins
title Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins
title_full Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins
title_fullStr Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins
title_full_unstemmed Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins
title_short Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins
title_sort comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350192/
https://www.ncbi.nlm.nih.gov/pubmed/37461708
http://dx.doi.org/10.21203/rs.3.rs-3089289/v1
work_keys_str_mv AT blumkealexander comparisonofosteoclastdifferentiationprotocolsfromhumaninducedpluripotentstemcellsofdifferenttissueorigins
AT ijeomaerica comparisonofosteoclastdifferentiationprotocolsfromhumaninducedpluripotentstemcellsofdifferenttissueorigins
AT simonjessica comparisonofosteoclastdifferentiationprotocolsfromhumaninducedpluripotentstemcellsofdifferenttissueorigins
AT wellingtonrachel comparisonofosteoclastdifferentiationprotocolsfromhumaninducedpluripotentstemcellsofdifferenttissueorigins
AT purwaningrummedania comparisonofosteoclastdifferentiationprotocolsfromhumaninducedpluripotentstemcellsofdifferenttissueorigins
AT doulatovsergei comparisonofosteoclastdifferentiationprotocolsfromhumaninducedpluripotentstemcellsofdifferenttissueorigins
AT leberelizabeth comparisonofosteoclastdifferentiationprotocolsfromhumaninducedpluripotentstemcellsofdifferenttissueorigins
AT scatenamarta comparisonofosteoclastdifferentiationprotocolsfromhumaninducedpluripotentstemcellsofdifferenttissueorigins
AT giachelliceciliam comparisonofosteoclastdifferentiationprotocolsfromhumaninducedpluripotentstemcellsofdifferenttissueorigins